ChemicalBook > Product Catalog >Pharmaceutical intermediates >Bulk Drug Intermediates >2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone

2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone

2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone Suppliers list
Company Name: Hebei Mojin Biotechnology Co., Ltd
Tel: +8613288715578
Email: sales@hbmojin.com
Products Intro: Product Name:(3R,4S,5R,6R)-3,4,5-tris(triMethylsilyloxy)-6-((triMethylsilyloxy)Methyl)tetrahydro-2H-pyran-2-on
CAS:32384-65-9
Purity:99.99% Package:25KG;60USD
Company Name: Shanghai Joiny Pharmaceutical Co.,LTD
Tel: +8613681955282
Email: gyd@joiny-pharma.com
Products Intro: Product Name:2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone
CAS:32384-65-9
Purity:98% Package:25kg
Company Name: Henan Bao Enluo International TradeCo.,LTD
Tel: +86-17331933971 +86-17331933971
Email: deasea125996@gmail.com
Products Intro: Product Name:(3R,4S,5R,6R)-3,4,5-tris(triMethylsilyloxy)-6-((triMethylsilyloxy)Methyl)tetrahydro-2H-pyran-2-on
CAS:32384-65-9
Purity:99% Package:1kg;10USD
Company Name: Hangzhou ICH Biofarm Co., Ltd
Tel: +undefined8613073685410
Email: sales@ichemie.com
Products Intro: Product Name:(3R,4S,5R,6R)-3,4,5-tris(triMethylsilyloxy)-6-((triMethylsilyloxy)Methyl)tetrahydro-2H-pyran-2-one
CAS:32384-65-9
Purity:99% Package:1kg;|5kg;|10kg
Company Name: Anhui Lianchuang Biological Medicine Co.,Ltd
Tel: +8619355958469
Email: sales7@lcywhx.com
Products Intro: Product Name:2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone
CAS:32384-65-9
Purity:99% Package:25KG;5KG;1KG

2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone manufacturers

2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone Basic information
Description Uses Reference
Product Name:2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone
Synonyms:(3R,4S,5R,6R)-3,4,5-tris(triMethylsilyloxy)-6-((triMethylsilyloxy)Methyl)tetrahydro-2H-pyran-2-one;(3R,4S,5R,6R)-3,4,5-Tris[(trimethylsilyl)oxy]-6-[[(trimethylsilyl)oxy]methyl]tetrahydropyran-2-one;D-2,3,4,6-Tetrakis-O-(trimethylsilyl)-gluconic acid delta-lactone;2,3,4,6-Tetrakis-O-triMethylsilyl-D-gluconolactoe;D-Gluconic acid, 2,3,4,6-tetrakis-O-(triMethylsilyl)-, d-lactone;2,3,4,6-tetrakis-O-trimethylsilyl-D-glucono1,5 lactone;(3R,5R,6R)-3,4,5-Tris((trimethylsilyl)oxy)-6-(((trimethylsilyl)oxy)methyl)tetrahydro-2H-pyran-2-one;(3R,4S,5R,6R)-3,4,5-tris(trimethylsilyloxy)-6-(trimethylsilyloxymethyl)oxan-2-one
CAS:32384-65-9
MF:C18H42O6Si4
MW:466.87
EINECS:608-732-8
Product Categories:32384-65-9
Mol File:32384-65-9.mol
2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone Structure
2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone Chemical Properties
Boiling point 417℃
density 0.97
Fp 171℃
storage temp. under inert gas (nitrogen or Argon) at 2-8°C
solubility Chloroform (Sparingly), Ethyl Acetate (Slightly), Methanol (Slightly)
form Oil
color Colourless to Pale Yellow
Stability:Moisture Sensitive
Safety Information
HS Code 2931900090
MSDS Information
2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone Usage And Synthesis
DescriptionIt is usually used as the intermediate and raw material in the chemistry synthesis and pharmaceutical industry. Especially, this chemical has been widely used in the design and synthesis of sodium-glucose transporter inhibitors.1 For example, this substance can be employed as raw material in the preparation of (1s)-1,5-anhydro-1-c-[4-chloro-3-[(4-ethoxylphenyl)methyl]phenyl]-D-glucitol, which is commonly known as Dapagliflozin that act as the sodium dependent glucose transporters for treating type 2 diabetes.2 Moreover, it can also function as the intermediate for synthesizing empagliflozin, which is a novel and selective sodium glucose co-transporter-2 inhibitor.3 In addition, canagliflozin, another sodium glucose co-transporter-2 inhibitor, can be obtained by utilizing this substance as the intermediate.4
Uses2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone is an antidiabetic agent and an intermediate of Dapagliflozin (D185370). 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone acts as a reagent in the synthesis of trans-cyclohexane-bearing C-glucose as sodium glucose co-transporter 2 inhibitors.
Reference
  1. Guo, C.; Hu, M.; DeOrazio, R. J.; Usyatinsky, A.; Fitzpatrick, K.; Zhang, Z. J.; Maeng, J. H.; Kitchen, D. B.; Tom, S.; Luche, M.; Khmelnitsky, Y.; Mhyre, A. J.; Guzzo, P. R.; Liu, S., The design and synthesis of novel SGLT2 inhibitors: C-glycosides with benzyltriazolopyridinone and phenylhydantoin as the aglycone moieties. Bioorg. Med. Chem. 2014, 22, 3414-3422.
  2. S Thirumalai Rajan; Eswaraiah, S., Process for the preparation of (1S)-1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxylphenyl)methyl]phenyl]-D-glucitol and its solvate thereof. US Patent 2015, WO 2015/132803 A2.
  3. Hrapchak, M.; Latli, B.; Wang, X. J.; Lee, H.; Campbell, S.; Song, J. J.; Senanayake, C. H., Synthesis of empagliflozin, a novel and selective sodium-glucose co-transporter-2 inhibitor, labeled with carbon-14 and carbon-13. J. Label. Compd. Radiopharm. 2014, 57, 687-694.
  4. Nomura, S.; Sakamaki, S.; Hongu, M.; Kawanishi, E.; Koga, Y.; Sakamoto, T.; Yamamoto, Y.; Ueta, K.; Kimata, H.; Nakayama, K.; Tsuda-Tsukimoto, M., Discovery of Canagliflozin, a Novel C-Glucoside with Thiophene Ring, as Sodium-Dependent Glucose Cotransporter 2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus. J. Med. Chem. 2010, 53, 6355-6360.
Chemical PropertiesPale yellow oil
Uses2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone is an antidiabetic agent and an intermediate of Dapagliflozin (D185370). 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone acts as a reagent in the synthesis of trans-cyclohexane-bearing C-glucose as sodium glucose co-transporter 2 inhibitors.
2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone Preparation Products And Raw materials
Tag:2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone(32384-65-9) Related Product Information
2-(5-BroMo-2-Methylbenzyl)-5-(4-fluorophenyl)thiophene 5-bromo-2-chloro-4’-ethoxydiphenylmethane (R)-3-(4-(5-broMo-2-chlorobenzyl)phenoxy)tetrahydrofuran 4-(5-broMo-2-chlorobenzyl)phenol Acarbose 5-Bromo-2-methylbenzoic acid D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]Methyl]-4-Methylphenyl]-, tetraacetate, (1S)- (9CI) (5-broMo-2-Methylphenyl)(5-(4-fluorophenyl)thiophen-2-yl)Methanone 2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene 5-Bromo-2-methylbenzoyl chloride 5-Iodo-2-methylbenzoic acid Canagliflozin heMihydrate LIPOPHILIC SEPHADEX 2-(4-Fluorophenyl)-thiophene BCP19353 Canagliflozin 5-Bromo-2-chlorobenzoic acid (5-broMo-2-chlorophenyl)(2-ethoxyphenyl)Methanone